Winton Group LTD Ovid Therapeutics Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$2.65 - $3.49 $31,346 - $41,283	-11,829 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$3.13 - $3.73 $132,170 - $157,506	-42,227 Reduced 78.12%	11,829 $38,000
Q3 2021 Oct 28, 2021	BUY	$3.31 - $4.04 $178,925 - $218,386	54,056 New	54,056 $182,000
Q4 2019 Feb 13, 2020	SELL	$2.08 - $5.06 $21,607 - $52,563	-10,388 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$1.76 - $3.51 $18,282 - $36,461	10,388 New	10,388 $34,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.